Johannes Gebert Selected Research

Johannes Gebert Research Topics

Disease

30	Neoplasms (Cancer) 06/2022 - 04/2003
26	Colorectal Neoplasms (Colorectal Cancer) 06/2022 - 04/2003
12	Microsatellite Instability 07/2020 - 01/2004
5	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 10/2021 - 05/2005
5	Colonic Neoplasms (Colon Cancer) 01/2019 - 09/2005
5	Carcinogenesis 01/2015 - 05/2005
2	Turcot syndrome 01/2018 - 04/2007
2	Neoplasm Metastasis (Metastasis) 01/2016 - 10/2015
2	Melanoma (Melanoma, Malignant) 04/2010 - 07/2009
2	Carcinoma (Carcinomatosis) 01/2009 - 11/2004
2	Adenoma (Adenomas) 01/2009 - 05/2005
2	Endometrial Neoplasms (Endometrial Cancer) 05/2006 - 01/2004
1	Stomach Neoplasms (Stomach Cancer) 04/2013
1	Glioma (Gliomas) 04/2007
1	Hyperplasia 01/2004

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 04/2021 - 09/2003
9	Transforming Growth Factor-beta Type II ReceptorIBA 10/2019 - 04/2003
6	Calcibiotic Root Canal SealerIBA 07/2020 - 06/2008
5	Peptides (Polypeptides)IBA 10/2021 - 09/2003
4	Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA 08/2019 - 01/2013
4	Glycoproteins (Glycoprotein)IBA 10/2015 - 01/2009
3	VaccinesIBA 10/2021 - 01/2018
3	Transforming Growth Factors (Transforming Growth Factor)IBA 10/2019 - 12/2014
3	Polysaccharides (Glycans)IBA 10/2015 - 07/2009
3	EpitopesIBA 01/2009 - 09/2003
2	Recombinases (Recombinase)IBA 06/2022 - 12/2014
2	Nonsense Codon (Nonsense Mutation)IBA 07/2020 - 05/2006
2	HLA-A Antigens (HLA-A)IBA 01/2020 - 07/2005
2	DNA (Deoxyribonucleic Acid)IBA 11/2015 - 09/2005
2	LectinsIBA 03/2015 - 07/2009
2	ProteomeIBA 01/2015 - 12/2014
2	Myosin Type I (Myosin IA)IBA 04/2013 - 01/2012
2	antineoplaston A10 (A 10)IBA 01/2013 - 11/2004
2	InterferonsIBA 04/2010 - 12/2007
1	Galectin 4 (LGALS4)IBA 06/2022
1	Naproxen (Naprosyn)FDA LinkGeneric 10/2021
1	Conditioned Culture MediaIBA 02/2021
1	MicroRNAs (MicroRNA)IBA 10/2019
1	RNA (Ribonucleic Acid)IBA 10/2019
1	Glutamine (L-Glutamine)FDA Link 01/2019
1	CarbonIBA 01/2019
1	Galectins (Galectin)IBA 12/2017
1	Stem Cell FactorIBA 01/2017
1	Interleukin-4 (Interleukin 4)IBA 01/2017
1	CytokinesIBA 01/2017
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 01/2017
1	AcetylglucosamineIBA 01/2016
1	GlycosyltransferasesIBA 01/2016
1	NectinsIBA 10/2015
1	Membrane Glycoproteins (Membrane Glycoprotein)IBA 10/2015
1	N-Acetylneuraminic Acid (Sialic Acid)IBA 10/2015
1	Glucose (Dextrose)FDA LinkGeneric 03/2015
1	Deoxyglucose (2 Deoxy D glucose)IBA 03/2015
1	AntimetabolitesIBA 03/2015
1	MonosaccharidesIBA 03/2015
1	Growth Differentiation Factor 15IBA 01/2015
1	Doxycycline (Periostat)FDA LinkGeneric 12/2014
1	AzidesIBA 12/2014
1	Alkynes (Acetylenes)IBA 12/2014
1	Activin Receptors (Activin Receptor)IBA 12/2014
1	Cycloheximide (Cicloheximide)IBA 04/2013
1	Decitabine FDA Link 04/2013
1	Messenger RNA (mRNA)IBA 04/2013
1	Galectin 3 (LGALS3)IBA 08/2012
1	Plant LectinsIBA 08/2012
1	AcetylgalactosamineIBA 08/2012
1	AgarIBA 01/2012
1	CarcinogensIBA 01/2012
1	Fibronectins (Fibronectin)IBA 04/2010
1	Epithelial Cell Adhesion MoleculeIBA 04/2010
1	Transforming Growth Factor beta (TGF-beta)IBA 07/2009
1	IntegrinsIBA 07/2009
1	Activins (Activin)IBA 07/2009
1	Mannose-Binding LectinsIBA 01/2009
1	Tyrosine (L-Tyrosine)FDA Link 11/2008
1	Protein Tyrosine PhosphatasesIBA 11/2008
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2008
1	Amino Acids FDA Link 05/2006
1	3' Untranslated Regions (3' UTR)IBA 09/2005
1	HLA Antigens (Human Leukocyte Antigens)IBA 07/2005
1	Monoclonal AntibodiesIBA 07/2005
1	Histocompatibility Antigens Class IIBA 07/2005
1	CaspasesIBA 11/2004
1	HLA-A*02:01 antigenIBA 11/2004
1	Combined VaccinesIBA 11/2004
1	beta CateninIBA 10/2004
1	AntigensIBA 09/2003
1	UDP-N-acetylglucosamine-peptide beta-N-acetylglucosaminyltransferaseIBA 09/2003

Therapy/Procedure

2	Therapeutics 10/2015 - 04/2007
2	Lasers (Laser) 05/2005 - 04/2003
1	Immunotherapy 04/2021
1	Chemoprevention 01/2018
1	Adjuvant Chemotherapy 09/2005